8-K 1 c78501e8vk.txt FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 22, 2003 ROCHESTER MEDICAL CORPORATION ------------------------------------------------------ (Exact name of registrant as specified in its charter) Minnesota 0-18933 41-1613227 ---------------------------- ------------------------ ------------------- (State or other jurisdiction (Commission file number) (I.R.S. Employer of incorporation) Identification No.) One Rochester Medical Drive, Stewartville, MN 55976 --------------------------------------------------- (Address of principal executive offices) Registrant's telephone number, including area code: (507) 533-9600 -------------- Not Applicable ------------------------------------------------------------- (Former name or former address, if changed since last report) ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS. (c) Exhibits. 99.1 Press Release, dated July 22, 2003, issued by Rochester Medical Corporation ITEM 9. REGULATION FD DISCLOSURE. On July 22, 2003, the Company issued a press release announcing operating results for its second quarter ending June 30, 2003. A copy of the press release is filed herewith as Exhibit 99.1 to this report and is incorporated herein by reference. The information furnished under "Item 9. Regulation FD Disclosure" is intended to be furnished under "Item 12. Results of Operations and Financial Condition" in accordance with SEC Release No. 33-8216. The information in this Form 8-K and the exhibit attached hereto shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Form 8-K shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. July 24, 2003 ROCHESTER MEDICAL CORPORATION By: /s/ David A. Jonas -------------------------------- David A. Jonas Chief Financial Officer EXHIBIT INDEX Exhibit No. Description ----------- ----------- 99.1 Press Release, dated July 22, 2003, issued by Rochester Medical Corporation